Magdalena Bieniasz to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Magdalena Bieniasz has written about Xenograft Model Antitumor Assays.
Connection Strength
0.353
-
Patient-derived tumor models are attractive tools to repurpose drugs for ovarian cancer treatment: pre-clinical updates. Oncotarget. 2022; 13:553-575.
Score: 0.178
-
Preclinical Efficacy of Ron Kinase Inhibitors Alone and in Combination with PI3K Inhibitors for Treatment of sfRon-Expressing Breast Cancer Patient-Derived Xenografts. Clin Cancer Res. 2015 Dec 15; 21(24):5588-600.
Score: 0.113
-
Potential and mechanism of mebendazole for treatment and maintenance of ovarian cancer. Gynecol Oncol. 2021 01; 160(1):302-311.
Score: 0.040
-
Photodynamic therapy augments the efficacy of oncolytic vaccinia virus against primary and metastatic tumours in mice. Br J Cancer. 2011 Nov 08; 105(10):1512-21.
Score: 0.022